Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.
- DOI
- 10.1016/j.cjco.2026.04.018
- Published
- 2026 Jul
- Container
- CJC open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cjco.2026.04.018,
title = {Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.},
author = {McDonald MA and Kok M and Ducharme A and Ezekowitz J and Howlett J and Rojas-Fernandez C and Udell JA},
year = {2026},
journal = {CJC open},
doi = {10.1016/j.cjco.2026.04.018},
url = {https://doi.org/10.1016/j.cjco.2026.04.018}
}RIS
TY - JOUR TI - Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data. AU - McDonald MA AU - Kok M AU - Ducharme A AU - Ezekowitz J AU - Howlett J AU - Rojas-Fernandez C AU - Udell JA PY - 2026 JO - CJC open DO - 10.1016/j.cjco.2026.04.018 UR - https://doi.org/10.1016/j.cjco.2026.04.018 ER -
APA
MA, M., M, K., A, D., J, E., J, H., C, R., & JA, U. (2026). Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.. CJC open. https://doi.org/10.1016/j.cjco.2026.04.018
Source records
- pubmed · retrieved 2026-09-25T12:47:25.452Z